Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma.
Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma.
复制标题
具核梭杆菌通过调节食管鳞状细胞癌中的自噬而产生耐药性。
DOI:
10.1038/s41416-020-01198-5
复制
发表时间:
2021-03
影响因子:
8.8
通讯作者:
Baba H
中科院分区:
文献类型:
--
作者:
Liu Y;Baba Y;Ishimoto T;Tsutsuki H;Zhang T;Nomoto D;Okadome K;Yamamura K;Harada K;Eto K;Hiyoshi Y;Iwatsuki M;Nagai Y;Iwagami S;Miyamoto Y;Yoshida N;Komohara Y;Ohmuraya M;Wang X;Ajani JA;Sawa T;Baba H
Fusobacterium nucleatum (F. nucleatum) is a gut microbe implicated in gastrointestinal tumorigenesis. Predicting the chemotherapeutic response is critical to developing personalised therapeutic strategies for oesophageal cancer patients. The present study investigated the relationship between F. nucleatum and chemotherapeutic resistance in oesophageal squamous cell carcinoma (ESCC). We examined the relationship between F. nucleatum and chemotherapy response in 120 ESCC resected specimens and 30 pre-treatment biopsy specimens. In vitro studies using ESCC cell lines and co-culture assays further uncovered the mechanism underlying chemotherapeutic resistance. ESCC patients with F. nucleatum infection displayed lesser chemotherapeutic response. The infiltration and subsistence of F. nucleatum in the ESCC cells were observed by transmission electron microscopy and laser scanning confocal microscopy. We also observed that F. nucleatum modulates the endogenous LC3 and ATG7 expression, as well as autophagosome formation to induce chemoresistance against 5-FU, CDDP, and Docetaxel. ATG7 knockdown resulted in reversal of F. nucleatum-induced chemoresistance. In addition, immunohistochemical studies confirmed the correlation between F. nucleatum infection and ATG7 expression in 284 ESCC specimens. F. nucleatum confers chemoresistance to ESCC cells by modulating autophagy. These findings suggest that targeting F. nucleatum, during chemotherapy, could result in variable therapeutic outcomes for ESCC patients.
登录
查看更多内容
影响因子:
6.3
作者:
Izumi, Dasiuke;Yoshida, Naoya;Baba, Hideo
通讯作者:
Baba, Hideo
影响因子:
6
作者:
Aghdaei, Hamid Asadzadeh;Kadijani, Azade Amini;Zali, Mohammad Reza
通讯作者:
Zali, Mohammad Reza
影响因子:
7
作者:
Castellarin, Mauro;Warren, Rene L.;Holt, Robert A.
通讯作者:
Holt, Robert A.
影响因子:
30.3
作者:
Rubinstein MR;Wang X;Liu W;Hao Y;Cai G;Han YW
通讯作者:
Han YW
影响因子:
15.5
作者:
Panebianco C;Andriulli A;Pazienza V
通讯作者:
Pazienza V